Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)
Clinical trial NCT02445053 · COMPLETED
Trial details
- NCT number
- NCT02445053
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-01
- Primary completion
- 2020-10-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.